- Home
- CNXC vs KYMR Comparison
CNXC vs KYMR Comparison
Compare CNXC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNXC
- KYMR
- Stock Information
- Founded
- CNXC 1991
- KYMR 2015
- Country
- CNXC United States
- KYMR United States
- Employees
- CNXC N/A
- KYMR N/A
- Industry
- CNXC Computer Software: Prepackaged Software
- KYMR Medicinal Chemicals and Botanical Products
- Sector
- CNXC Technology
- KYMR Health Care
- Exchange
- CNXC Nasdaq
- KYMR Nasdaq
- Market Cap
- CNXC 3.3B
- KYMR 3.1B
- IPO Year
- CNXC N/A
- KYMR 2020
- Fundamental
- Price
- CNXC $57.10
- KYMR $51.16
- Analyst Decision
- CNXC Buy
- KYMR Strong Buy
- Analyst Count
- CNXC 4
- KYMR 17
- Target Price
- CNXC $69.50
- KYMR $60.18
- AVG Volume (30 Days)
- CNXC 625.2K
- KYMR 679.6K
- Earning Date
- CNXC 09-25-2025
- KYMR 10-30-2025
- Dividend Yield
- CNXC 2.34%
- KYMR N/A
- EPS Growth
- CNXC N/A
- KYMR N/A
- EPS
- CNXC 3.65
- KYMR N/A
- Revenue
- CNXC $9,625,029,000.00
- KYMR $44,711,000.00
- Revenue This Year
- CNXC $3.62
- KYMR $63.75
- Revenue Next Year
- CNXC $3.16
- KYMR N/A
- P/E Ratio
- CNXC $15.59
- KYMR N/A
- Revenue Growth
- CNXC 11.31
- KYMR N/A
- 52 Week Low
- CNXC $36.28
- KYMR $19.45
- 52 Week High
- CNXC $66.00
- KYMR $53.27
- Technical
- Relative Strength Index (RSI)
- CNXC 64.72
- KYMR 71.70
- Support Level
- CNXC $52.93
- KYMR $47.86
- Resistance Level
- CNXC $57.56
- KYMR $44.43
- Average True Range (ATR)
- CNXC 2.03
- KYMR 2.01
- MACD
- CNXC 0.55
- KYMR 0.84
- Stochastic Oscillator
- CNXC 93.92
- KYMR 94.65
About CNXC Concentrix Corporation
Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.